Latest News and Press Releases
Want to stay updated on the latest news?
-
MIDLAND, Texas, May 18, 2007 (PRIME NEWSWIRE) -- Legacy Reserves LP (Nasdaq:LGCY) today announced it entered into NYMEX WTI Oil swaps and Waha natural gas swaps related to its previously announced...
-
NEW YORK, May 18, 2007 (PRIME NEWSWIRE) -- This week's Wall Street Journal Weekend Edition centerpiece will focus on a provision that would allow immigrant shepherds to apply for a green card after...
-
HARTFORD, Conn., May 18, 2007 (PRIME NEWSWIRE) -- Scott + Scott, LLC and Johnson & Perkinson Announces the Notice of Pendency of Class Action and Proposed Settlement of a Class Action Involving...
-
NEW YORK, May 18, 2007 (PRIME NEWSWIRE) -- PIMCO California Municipal Income Fund II (NYSE: PCK) and PIMCO New York Municipal Income Fund II (NYSE: PNI) (the "Funds") today announced their results for...
-
NEW YORK, May 18, 2007 (PRIME NEWSWIRE) -- PIMCO Municipal Income Fund II (the "Fund") (NYSE:PML), a closed-end management investment company which seeks to provide current income exempt from federal...
-
SAN DIEGO, May 18, 2007 (PRIME NEWSWIRE) -- WFI (Nasdaq:WFII) today announced that on May 14, 2007 it received a staff determination letter from the Nasdaq Stock Market ("Nasdaq") advising the Company...
-
ADVISORY, May 18, 2007 (PRIME NEWSWIRE) -- Who: NASDAQ President and CEO Robert Greifeld What: Mr. Greifeld will speak at the Fox-Pitt, Kelton Global Exchange Conference. The...
-
ADVISORY, May 18, 2007 (PRIME NEWSWIRE) -- What: Cathleen C. Laporte, Founder & President of Athletes for Charity, Inc., will preside over the closing bell. Where: NASDAQ MarketSite - 4...
-
HOUSTON, May 18, 2007 (PRIME NEWSWIRE) -- Transocean Inc. (NYSE:RIG) today announced that Gregory L. Cauthen, Senior Vice President of the company, will address attendees at the UBS Global Oil and Gas...
-
Basel, Switzerland, May 18, 2007 - Basilea Pharmaceutica Ltd. (SWX:BSLN) announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ceftobiprole...